In conclusion, we revealed that USP8 is a novel PD-L1 deubiquitinating enzyme that upregulates PD-L1 levels by inhibiting the ubiquitination-regulated proteasome degradation pathway, thereby promoting pancreatic tumor growth via immune evasion. This evidence concerns the gene CD274 and pancreatic neoplasm.